APOBEC3A and cancer: The SBS2 and SBS13 mutations generated in the cancer cell lines in vitro were largely enriched in the YTCN/YTCA sequence context (where Y is a pyrimidine), consistent with episodic mutagenesis mainly being mediated by APOBEC3A (Figure S4C; STAR Methods).